Unexpected regulatory roles of TLR4 and TLR9 in experimental autoimmune encephalomyelitis

European Journal of Immunology

Volumn 38, Issue 2, 2008, Pages 565-575

  Marta, Monica ^a   Andersson, Åsa ^a,b   Isaksson, Magnus ^c   Kämpe, Olle ^c   Lobell, Anna ^a,c  

^a KAROLINSKA INSTITUTE   (Sweden)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Antigen presenting cells; Autoimmunity; Cytokines; Innate immunity; T helper cells

Indexed keywords

ADAPTOR PROTEIN; INTERLEUKIN 17; INTERLEUKIN 23; INTERLEUKIN 6; MYELIN OLIGODENDROCYTE GLYCOPROTEIN; MYELOID DIFFERENTIATION FACTOR 88; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 9; MYD88 PROTEIN, MOUSE; MYELIN ASSOCIATED GLYCOPROTEIN; OLIGODENDROCYTE MYELIN GLYCOPROTEIN; OLIGODENDROCYTE-MYELIN GLYCOPROTEIN; TLR4 PROTEIN, MOUSE; TLR9 PROTEIN, MOUSE; UNCLASSIFIED DRUG;

ADAPTIVE IMMUNITY; ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL ACTIVATION; CONTROLLED STUDY; DISEASE SEVERITY; IMMUNE RESPONSE; IMMUNIZATION; INNATE IMMUNITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY T LYMPHOCYTE; SPLEEN CELL; T LYMPHOCYTE; ANIMAL; C57BL MOUSE; CELL CULTURE; FEMALE; GENETICS; HOSPITALIZATION; IMMUNOLOGY; METABOLISM; MOUSE MUTANT; PHYSIOLOGY;

ANIMALS; CELLS, CULTURED; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MYELIN-ASSOCIATED GLYCOPROTEIN; MYELOID DIFFERENTIATION FACTOR 88; SEVERITY OF ILLNESS INDEX; TOLL-LIKE RECEPTOR 4; TOLL-LIKE RECEPTOR 9;

EID: 42249109064     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/eji.200737187     Document Type: Article

References (51)

1. Banchereau, J. and Steinman, R. M., Dendritic cells and the control of immunity. Nature 1998. 392: 245-252.
2. Pasare, C. and Medzhitov, R., Toll-like receptors and acquired immunity. Semin. Immunol. 2004. 16: 23-26.
3. Kawai, T. and Akira, S., Pathogen recognition with Toll-like receptors. Curr. Opin. Immunol. 2005. 17: 338-344.
4. Honda, K., Yanai, H., Negishi, H., Asagiri, M., Sato, M., Mizutani, T., Shimada, N. et al., IRF-7 is the master regulator of type-I interferon-dependent immune responses. Nature 2005. 434: 772-777.
5. Takeda, K. and Akira, S., TLR signaling pathways. Semin. Immunol. 2004. 16: 3-9.
6. Steinman, L., Martin, R., Bernard, C., Conlon, P. and Oksenberg, J. R., Multiple sclerosis: Deeper understanding of its pathogenesis reveals new targets for therapy. Annu. Rev. Neurosci. 2002. 25: 491-505.
7. Heldwein, K. A., Liang, M. D., Andresen, T. K., Thomas, K. E., Marty, A. M., Cuesta, N., Vogel, S. N. and Fenton, M. J., TLR2 and TLR4 serve distinct roles in the host immune response against Mycobacterium bovis BCG. J. Leukoc. Biol. 2003. 74: 277-286.
8. Heldwein, K. A. and Fenton, M. J., The role of Toll-like receptors in immunity against mycobacterial infection. Microbes Infect. 2002. 4: 937-944.
9. Krieg, A. M., CpG motifs in bacterial DNA and their immune effects. Annu. Rev. Immunol. 2002. 20: 709-760.
10. Kerfoot, S.M., Long, E. M., Hickey, M. J., Andonegui, G., Lapointe, B. M., Zanardo, R. C., Bonder, C. et al., TLR4 contributes to disease-inducing mechanisms resulting in central nervous system autoimmune disease. J. Immunol. 2004. 173: 7070-7077.
11. Schnare, M., Barton, G. M., Holt, A. C., Takeda, K., Akira, S. and Medzhitov, R., Toll-like receptors control activation of adaptive immune responses. Nat. Immunol. 2001. 2: 947-950.
12. Langrish, C. L., Chen, Y., Blumenschein, W. M., Mattson, J., Basham, B., Sedgwick, J. D., McClanahan, T. et al., IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J. Exp. Med. 2005. 201: 233-240.
13. Harrington, L. E., Hatton, R. D., Mangan, P. R., Turner, H., Murphy, T. L., Murphy, K. M. and Weaver, C. T., Interleukin 17-producing CD4(+) effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat. Immunol. 2005. 6: 1123-1132.
14. Park, H., Li, Z., Yang, X. O., Chang, S. H., Nurieva, R., Wang, Y. H., Wang, Y. et al., A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat. Immunol. 2005. 6: 1133-1141.
15. Mangan, P. R., Harrington, L. E., O'Quinn, D. B., Helms,W. S., Bullard, D. C., Elson, C. O., Hatton, R. D. et al., Transforming growth factor-beta induces development of the T(H)17 lineage. Nature 2006. 441: 231-234.
16. Bettelli, E., Carrier, Y., Gao, W., Korn, T., Strom, T. B., Oukka, M., Weiner, H. L. and Kuchroo, V. K., Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 2006. 441: 235-238.
17. Veldhoen, M., Hocking, R. J., Atkins, C. J., Locksley, R. M. and Stockinger, B., TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity 2006. 24: 179-189.
18. Sutton, C., Brereton, C., Keogh, B., Mills, K. H. and Lavelle, E. G., A crucial role for interleukin (IL)-1 in the induction of IL-17-producing T cells that mediate autoimmune encephalomyelitis. J. Exp. Med. 2006. 203: 1685-1691.
19. Prinz, M., Garbe, F., Schmidt, H., Mildner, A., Gutcher, I., Wolter, K., Piesche, M. et al., Innate immunity mediated by TLR9 modulates pathogenicity in an animal model of multiple sclerosis. J. Clin. Invest. 2006. 116: 456-464.
20. Hansen, B. S., Hussain, R. Z., Lovett-Racke, A. E., Thomas, J. A. and Racke, M. K., Multiple toll-like receptor agonists act as potent adjuvants in the induction of autoimmunity. J. Neuroimmunol. 2006. 172: 94-103.
21. Lobell, A.,Weissert, R., Eltayeb, S., Svanholm, C., Olsson, T. and Wigzell, H., Presence of CpG DNA and the local cytokine milieu determine the efficacy of suppressive DNA vaccination in experimental autoimmune encephalomyelitis. J. Immunol. 1999. 163: 4754-4762.
22. Adachi, O., Kawai, T., Takeda, K., Matsumoto, M., Tsutsui, H., Sakagami, M., Nakanishi, K. and Akira, S., Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function. Immunity 1998. 9: 143-150.
23. Parham, C., Chirica, M., Timans, J., Vaisberg, E., Travis, M., Cheung, J., Pflanz, S. et al., A receptor for the heterodimeric cytokine IL-23 is composed of IL-12Rbeta1 and a novel cytokine receptor subunit, IL-23R. J. Immunol. 2002. 168: 5699-5708.
24. Bafica, A., Scanga, C. A., Feng, C. G., Leifer, C., Cheever, A. and Sher, A., TLR9 regulates Th1 responses and cooperates with TLR2 in mediating optimal resistance to Mycobacterium tuberculosis. J. Exp. Med. 2005. 202: 1715-1724.
25. Honda, K., Ohba, Y., Yanai, H., Negishi, H., Mizutani, T., Takaoka, A., Taya, C. and Taniguchi, T., Spatiotemporal regulation of MyD88-IRF-7 signalling for robust type-I interferon induction. Nature 2005. 434: 1035-1040.
26. Chen, Y., Inobe, J., Kuchroo, V. K., Baron, J. L., Janeway, C. A., Jr. and Weiner, H. L., Oral tolerance in myelin basic protein T-cell receptor transgenic mice: Suppression of autoimmune encephalomyelitis and dose-dependent induction of regulatory cells. Proc. Natl. Acad. Sci. USA 1996. 93: 388-391.
27. Shi, F. D., Bai, X. F., Xiao, B. G., van der Meide, P. H. and Link, H., Nasal administration of multiple antigens suppresses experimental autoimmune myasthenia gravis, encephalomyelitis and neuritis. J. Neurol. Sci. 1998. 155: 1-12.
28. + T cell-mediated suppression by dendritic cells. Science 2003. 299: 1033-1036.
29. Vallin, H., Perers, A., Alm, G. V. and Ronnblom, L., Anti-double-stranded DNA antibodies and immunostimulatory plasmid DNA in combination mimic the endogenous IFN-alpha inducer in systemic lupus erythematosus. J. Immunol. 1999. 163: 6306-6313.
30. Bave, U., Nordmark, G., Lovgren, T., Ronnelid, J., Cajander, S., Eloranta, M. L., Alm, G. V. and Ronnblom, L., Activation of the type I interferon system in primary Sjogren's syndrome: A possible etiopathogenic mechanism. Arthritis Rheum. 2005. 52: 1185-1195.
31. Lau, C. M., Broughton, C., Tabor, A. S., Akira, S., Flavell, R. A., Mamula, M. J., Christensen, S. R. et al., RNA-associated autoantigens activate B cells by combined B cell antigen receptor/ Toll-like receptor 7 engagement. J. Exp. Med. 2005. 202: 1171-1177.
32. Leadbetter, E. A., Rifkin, I. R., Hohlbaum, A. M., Beaudette, B. C., Shlomchik, M. J. and Marshak-Rothstein, A., Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors. Nature 2002. 416: 603-607.
33. Christensen, S. R., Kashgarian, M., Alexopoulou, L., Flavell, R. A., Akira, S. and Shlomchik, M. J., Toll-like receptor 9 controls anti-DNA autoantibody production in murine lupus. J. Exp. Med. 2005. 202: 321-331.
34. Christensen, S. R., Shupe, J., Nickerson, K., Kashgarian, M., Flavell, R. A. and Shlomchik, M. J., Toll-like receptor 7 and TLR9 dictate autoantibody specificity and have opposing inflammatory and regulatory roles in a murine model of lupus. Immunity 2006. 25: 417-428.
35. Wefer, J., Harris, R. A. and Lobell, A., Protective DNA vaccination against experimental autoimmune encephalomyelitis is associated with induction of IFNbeta. J. Neuroimmunol. 2004. 149: 66-76.
36. Lobell, A., Weissert, R., Eltayeb, S., de Graaf, K. L., Wefer, J., Storch, M. K., Lassmann, H. et al., Suppressive DNA vaccination in myelin oligodendrocyte glycoprotein peptide-induced experimental autoimmune encephalomyelitis involves a T1-biased immune response. J. Immunol. 2003. 170: 1806-1813.
37. Willenborg, D. O., Fordham, S., Bernard, C. C., Cowden, W. B. and Ramshaw, I. A., IFN-gamma plays a critical down-regulatory role in the induction and effector phase of myelin oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis. J. Immunol. 1996. 157: 3223-3227.
38. Segal, B. M., Chang, J. T. and Shevach, E. M., CpG oligonucleotides are potent adjuvants for the activation of autoreactive encephalitogenic T cells in vivo. J. Immunol. 2000. 164: 5683-5688.
39. Waldner, H., Collins, M. and Kuchroo, V. K., Activation of antigen-presenting cells by microbial products breaks self tolerance and induces autoimmune disease. J. Clin. Invest. 2004. 113: 990-997.
40. Iglesias, A., Bauer, J., Litzenburger, T., Schubart, A. and Linington, C., T-and B-cell responses to myelin oligodendrocyte glycoprotein in experimental autoimmune encephalomyelitis and multiple sclerosis. Glia 2001. 36: 220-234.
41. Lyons, J. A., San, M., Happ, M. P. and Cross, A. H., B cells are critical to induction of experimental allergic encephalomyelitis by protein but not by a short encephalitogenic peptide. Eur. J. Immunol. 1999. 29: 3432-3439.
42. Goverman, J., Perchellet, A. and Huseby, E. S., The role of CD8(+) T cells in multiple sclerosis and its animal models. Curr. Drug Targets Inflamm. Allergy 2005. 4: 239-245.
43. + T cell populations lacking helper function. Nat. Immunol. 2005. 6: 163-170.
44. McMahon, E. J., Bailey, S. L., Castenada, C. V., Waldner, H. and Miller, S. D., Epitope spreading initiates in the CNS in two mouse models of multiple sclerosis. Nat. Med. 2005. 11: 335-339.
45. Greter, M., Heppner, F. L., Lemos, M. P., Odermatt, B. M., Goebels, N., Laufer, T., Noelle, R. J. and Becher, B., Dendritic cells permit immune invasion of the CNS in an animal model of multiple sclerosis. Nat. Med. 2005. 11: 328-334.
46. Erlandsson Harris, H. and Andersson, U., Mini-review: The nuclear protein HMGB1 as a proinflammatory mediator. Eur. J. Immunol. 2004. 34: 1503-1512.
47. Weissert, R., Wallstrom, E., Storch, M. K., Stefferl, A., Lorentzen, J., Lassmann, H., Linington, C. and Olsson, T., MHC haplotype-dependent regulation of MOG-induced EAE in rats. J. Clin. Invest. 1998. 102: 1265-1273.
48. LeibundGut-Landmann, S., Waldburger, J. M., Reis e Sousa, C., Acha-Orbea, H. and Reith, W., MHC class II expression is differentially regulated in plasmacytoid and conventional dendritic cells. Nat. Immunol. 2004. 5: 899-908.
49. Hemmi, H., Kaisho, T., Takeda, K. and Akira, S., The roles of Toll-like receptor 9, MyD88, and DNA-dependent protein kinase catalytic subunit in the effects of two distinct CpG DNAs on dendritic cell subsets. J. Immunol. 2003. 170: 3059-3064.
50. Swanberg, M., Lidman, O., Padyukov, L., Eriksson, P., Akesson, E., Jagodic, M., Lobell, A. et al., MHC2TA is associated with differential MHC molecule expression and susceptibility to rheumatoid arthritis, multiple sclerosis and myocardial infarction. Nat. Genet. 2005. 37: 486-494.
51. Cua, D. J., Sherlock, J., Chen, Y., Murphy, C. A., Joyce, B., Seymour, B., Lucian, L. et al., Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain. Nature 2003. 421: 744-748.